Data / Form D filings / Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc.: Form D filings
Volastra Therapeutics, Inc., a pharmaceuticals company in New York, NY, filed 3 Form D notices with the SEC between 2023 and 2025. The latest, on September 23, 2025, reports $30.1 million sold of a $30.1 million offering to 11 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1361 AMSTERDAM AVENUE, SUITE 520, New York, NY, 10027
- Phone
- (646) 344-1248
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1968822
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 23, 2025 | New notice | $30,099,998 | $30,099,998 | 11 | Sep 8, 2025 | sec.gov | |
| May 30, 2024 | New notice | $15,000,000 | $15,000,000 | 2 | May 17, 2024 | sec.gov | |
| Mar 13, 2023 | New notice | $60,174,997 | $60,174,997 | 13 | Mar 3, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Sandra Peterson | Director | |
| Robert Mittendorff | Director | |
| Jill Goldstein | Director | |
| David Southwell | Executive Officer, Director | |
| Arjun Balar | Director | |
| Samuel Bakhoum | Director | |
| Ellie McGuire | Director | |
| Luc Dochez | Director | |
| David Nicholson | Director |
Other pharmaceuticals companies in New York that filed recently
- Pierrepont Therapeutics, Inc. $2.4 million · Sep 22, 2026
Every Form D from the week of Sep 22, 2025 · All recent filings in New York · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Volastra Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.